To confirm this result, we compared the activity of Oct-1 promoters in normal hematopietic cells and in the tumor cells lines of B- and T-cell origin by qRT-PCR using the corresponding primers (Materials and Methods) (Figure 4). This evidence concerns the gene POU2F1 and neoplasm.